Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
09 December 2022 | Story Rulanzen Martin | Photo Barend Nagel
From the left: Rulanzen Martin, Lacea Loader, Dr Nitha Ramnath, and Martie Nortjé.

Another year, another round of national and international awards for the Department of Communication and Marketing’s (DCM) campaigns and projects. This year saw DCM pick up an International Association of Business Communicators (IABC) Africa Silver Quill Award of Excellence for Communication Research for Narrative Building Storytelling. This project and subsequent award were in partnership with Development Communication Solutions (DevCom), led by Lacea Loader, Director: Communication and Marketing. 

During the 2022 annual Marketing, Advancement and Communication in Education (MACE) Excellence Awards, DCM won four excellence awards. Dr Nitha Ramnath, Deputy Director: Corporate Relations, won a Silver Award of Excellence for the 2021 Rector’s Concert, and a Bronze Award of Excellence for the 2022 Rector’s Concert. 

Lacea Loader and Martie Nortjé, Manager: Reputation, Brand and Marketing Management, won a Bronze Award of Excellence for the project ‘UFS – Our Story: The building and implementation of a brand narrative.’ Rounding up the UFS’ winning tally was Website Editor, Rulanzen Martin, who won a MACE Bronze Award of Excellence for the 2021 UFS Deaf Awareness Month (DAM) Campaign. The DAM campaign also received recognition during the 2021 IABC Silver Quill awards, where it won a Silver Quill Award of Excellence. 

Awards a perfect opportunity to benchmark 

“The awards give recognition to the communication efforts and endeavours undertaken by DCM as the strategic communication partner at the UFS; it also serves as a perfect opportunity to benchmark against peers and the industry. I am extremely proud of what the team has achieved,” says Loader.  “It is an honour when our projects receive awards, given the calibre of entries submitted for both the IABC and MACE awards programmes. The IABC awards programme is for all industries, while the MACE awards only recognise higher education institutions,” she says. 

For the 2022 MACE Excellence Awards, a total of 95 awards were awarded to 12 institutions from a total of 171 entries.

News Archive

UFS takes a leading role in nuclear medicine and technology
2011-12-06

 
Photo: Dr Glen Taylor

The University of the Free State (UFS) continues to play an active role in the field of Nuclear Medicine and the use of nuclear technology in the biosciences. Dr Glen Taylor, Director of Research Commercialisation and Business Development at the UFS, was recently elected chairperson of the board for the Nuclear Technologies in Medicine and the Biosciences Initiative (NTeMBI).

The UFS is currently one of three centres of excellence in the country identified by the Nuclear Energy Corporation South African (Necsa) to roll out the capacity development programme and increase technology coming from nuclear medicine and technology.
NTeMBI is a national technology platform that is managed by Necsa and supported by the Department of Science and Technology (DST). It functions as a high-level Research, Development and Innovation (RD&I) initiative that will implement new strategic initiatives relating to research and development on nuclear technologies in medicine and the biosciences on a local, regional and international level. 
 
One of the roles Dr Taylor will perform as Chairperson of the board of NTeMBI, is to enhance the exposure of nuclear technology in medicine and the biosciences. Dr Taylor says the aim is to increase the skills base in South Africa. “I realise it is one of the scare skills in the country.” 
 
The UFS already received a significant amount of funding from the grant of R4 million per annum made available from the Department of Science and Technology (DST) to implement NTeMBI projects.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept